AcademicJobs.com Jobs

AcademicJobs.com

Applications Close:

5 Star Employer Ranking

"Molecular Pathology Technologist - James Molecular Laboratory"

Academic Connect
Applications Close

Molecular Pathology Technologist - James Molecular Laboratory

Scope of Position

The James Molecular Pathology Laboratory performs clinical molecular diagnostics testing and uniquely spans across the research and clinical missions of The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital (OSUCCC-James). The OSUCCC-James is committed to providing the community/region it serves with high quality services in cancer detection, diagnosis, treatment and rehabilitation as one of the nations? 10 free standing ?cancer-only? hospitals which, with 300+ beds, is one of the largest PPS-exempt hospitals in the USA (2500+ FTE?s). As an NCI designated Cancer program, the OSUCCC-James encompasses over 400,000 outpatient and clinic patient visits, more than 14,500 hospital admissions and over 10,000 surgeries per year. The CAP-, JCAHO- and CLIA-certified molecular laboratory is recognized as one of the top academic centers performing highly complex genetic testing utilizing advanced technology. It supports outreach testing programs, multi-institution cooperative efforts and educational rotations for medical students, residents, fellows and faculty from internal and external institutions. The Molecular Pathology Technologist will perform clinical and research work utilizing: molecular techniques and assays, nucleic acid isolations, polymerase chain reaction (PCR), capillary electrophoresis, sequencing and fluorescent in situ hybridization (FISH) techniques using formalin fixed paraffin imbedded tissue. Assays are performed under the supervision of the Medical Director, Division Director, Operations Director, Manager and Lead Technologist(s). The laboratory is regularly staffed five days a week (Monday through Friday) with weekend hours as needed.

Position Summary

A Molecular Pathology Technologist will perform clinical and research work utilizing: molecular techniques and assays, nucleic acid isolations, polymerase chain reaction (PCR), capillary electrophoresis, fragment analysis, genotyping, sequencing, cell culturing, fluorescent in situ hybridization (FISH) techniques using formalin fixed paraffin imbedded tissue, aliquots samples, specimen processing and testing services; verifies and reports test results. Laboratory staff performs and documents quality control, proficiency testing, quality assurance and preventative maintenance on instrumentation. The molecular technologist works under the direction of the lab manager, lead technologist(s) and division director(s).

Minimum Education Required

Bachelor's Level Degree

Required Qualifications

Bachelor's degree in medical technology & MT (ASCP) certification within one year of hire or Bachelor's degree in a biological science with post-degree experience in Molecular Biology & MB (ASCP) certification within two years of hire or advanced post-degree in Molecular Genetics, certification not required. Background in genetics and biochemistry desired. Experience with fluorescent in situ hybridization (FISH) techniques.

Career Roadmap

FUNCTION: Clinical Labs
SUB-FUNCTION: Molecular Pathology
CAREER BAND: Individual Contributor - Clinical
CAREER LEVEL: C2

10

Unlock this job opportunity


View more options below

View full job details

See the complete job description, requirements, and application process

Stay on their radar

Join the talent pool for AcademicJobs.com

Join Talent Pool

Express interest in this position

Let AcademicJobs.com know you're interested in Molecular Pathology Technologist - James Molecular Laboratory

Add this Job Post to FavoritesExpress Interest

Get similar job alerts

Receive notifications when similar positions become available

Share this opportunity

Send this job to colleagues or friends who might be interested

4,260 Jobs Found

AcademicJobs.com

Seattle, Washington
Staff / Administration
Add this Job Post to Favorites
Closes: Apr 20, 2026
View More